Despite COVID-19, Biotech Companies Find Ways to Expand their Footprints

When COVID-19 hit, the disease forced companies to alter the way business was conducted and changed the way research could be conducted onsite from the implementation of social distancing rules.

While standard operating procedures may have faced an adjustment, the global pandemic has not altered the plans for some companies to expand their physical footprint in the United States and elsewhere.